論文

国際誌
2021年6月

Significant Improvement After Surgery for a Symptomatic Osteoblastoma in a Patient with Camurati-Engelmann Disease: Case Report and Literature Review.

Calcified tissue international
  • Hirotaka Yonezawa
  • Katsuhiro Hayashi
  • Norio Yamamoto
  • Akihiko Takeuchi
  • Kaoru Tada
  • Shinji Miwa
  • Kentaro Igarashi
  • Hiroaki Kimura
  • Yu Aoki
  • Sei Morinaga
  • Yoshihiro Araki
  • Yohei Asano
  • Keisuke Sakurakichi
  • Hiroko Ikeda
  • Takayuki Nojima
  • Hiroyuki Tsuchiya
  • 全て表示

108
6
開始ページ
819
終了ページ
824
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1007/s00223-021-00813-8

Camurati-Engelmann disease (CED) is a rare, progressive diaphyseal dysplasia characterized as diaphyseal hyperostosis and sclerosis of the long bones. Corticosteroids, bisphosphonates, and losartan have been reported to be effective systemic medications used to reduce CED symptoms. There are no reports of osteoblastoma in patients with CED, and osteoblastoma in the distal radius is rare. We present a patient diagnosed with CED, based on radiological and histological examinations, at 11 years old. At 22 years old, she experienced severe pain in her right forearm and was treated with bisphosphonate, losartan, and prednisolone; however, the pain continued. An expansive and sclerotic lesion at the distal radius was observed on radiography. A follow-up plain radiograph indicated that the lesion was growing. Fluorodeoxyglucose positron emission tomography revealed solitary, intense radiotracer uptake, and a biopsy and surgical resection were performed due to suspected malignancy. Pathologic analysis showed anastomosing bony trabeculae rimmed by osteoblasts observed in a loose fibrovascular stroma. The lesion was diagnosed as an osteoblastoma. Following bone excision and artificial bone grafting, the patient's severe pain almost completely disappeared. At final follow-up, no evidence of osteoblastoma recurrence was noted. To our knowledge, this is the first case report of osteoblastoma arising in a patient with CED. Bone excision and artificial bone grafting may be a treatment option for local symptomatic osteoblastoma in patients with CED.

リンク情報
DOI
https://doi.org/10.1007/s00223-021-00813-8
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/33555353
ID情報
  • DOI : 10.1007/s00223-021-00813-8
  • PubMed ID : 33555353

エクスポート
BibTeX RIS